Literature DB >> 16286223

Pediculosis capitis.

Alexander K C Leung1, Justine H S Fong, Alfredo Pinto-Rojas.   

Abstract

Pediculosis capitis is a worldwide public health concern. Infestation occurs most commonly in children, with a peak incidence between 5 to 11 years of age. The condition is more common in girls and less common in Black children. Direct head-to-head contact is the most common mode of transmission. Pruritus is the most common symptom of infestation. The gold standard for diagnosing pediculosis capitis is finding a live louse or nymph in the scalp or viable egg in the scalp hair. Pediculicides are the most effective treatment. All household members and close contacts should be examined and treated concurrently if infested. The child should be allowed to return to school or to a child care facility after proper treatment. The child should be discouraged from close, direct head contact with others or from sharing items that have come in contact with the hair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286223     DOI: 10.1016/j.pedhc.2005.07.002

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  17 in total

Review 1.  Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method.

Authors:  Giao Do-Pham; Laurence Le Cleach; Bruno Giraudeau; Annabel Maruani; Olivier Chosidow; Philippe Ravaud
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

2.  The prevalence of pediculus capitis among the middle schoolchildren in Fars Province, southern Iran.

Authors:  Mohammad Ali Davarpanah; Akbar Rasekhi Kazerouni; Hashem Rahmati; Roxana Neirami Neirami; Hamid Bakhtiary; Mohammad Sadeghi
Journal:  Caspian J Intern Med       Date:  2013

3.  Epidemiological comparative study of pediculosis capitis among primary school children in Fayoum and Minofiya governorates, Egypt.

Authors:  Talal A Abd El Raheem; Naglaa A El Sherbiny; Alkasseem Elgameel; Ghada A El-Sayed; Nada Moustafa; Sally Shahen
Journal:  J Community Health       Date:  2015-04

4.  Head lice prevalence among households in Norway: importance of spatial variables and individual and household characteristics.

Authors:  Bjørn Arne Rukke; Tone Birkemoe; Arnulf Soleng; Heidi Heggen Lindstedt; Preben Ottesen
Journal:  Parasitology       Date:  2011-07-18       Impact factor: 3.234

5.  Head lice in Norwegian households: actions taken, costs and knowledge.

Authors:  Bjørn Arne Rukke; Tone Birkemoe; Arnulf Soleng; Heidi Heggen Lindstedt; Preben Ottesen
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Socioeconomic status, family background and other key factors influence the management of head lice in Norway.

Authors:  Bjørn Arne Rukke; Arnulf Soleng; Heidi Heggen Lindstedt; Preben Ottesen; Tone Birkemoe
Journal:  Parasitol Res       Date:  2014-03-08       Impact factor: 2.289

Review 7.  Treatment of Pediculosis Capitis.

Authors:  Prashant Verma; Chaitanya Namdeo
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

8.  Molecular survey of the head louse Pediculus humanus capitis in Thailand and its potential role for transmitting Acinetobacter spp.

Authors:  Sakone Sunantaraporn; Vivornpun Sanprasert; Theerakamol Pengsakul; Atchara Phumee; Rungfar Boonserm; Apiwat Tawatsin; Usavadee Thavara; Padet Siriyasatien
Journal:  Parasit Vectors       Date:  2015-02-26       Impact factor: 3.876

9.  Activity of tea tree oil and nerolidol alone or in combination against Pediculus capitis (head lice) and its eggs.

Authors:  Emanuela Di Campli; Soraya Di Bartolomeo; Patricia Delli Pizzi; Mara Di Giulio; Rossella Grande; Antonia Nostro; Luigina Cellini
Journal:  Parasitol Res       Date:  2012-07-31       Impact factor: 2.289

10.  Survey assessment on pediatricians' attitudes on head lice management.

Authors:  Claudia Fancelli; Manuela Prato; Carlotta Montagnani; Monica Pierattelli; Paolo Becherucci; Elena Chiappini; Maurizio de Martino; Luisa Galli
Journal:  Ital J Pediatr       Date:  2013-10-03       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.